Ostrum Asset Management Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ostrum Asset Management decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,167 shares of the medical equipment provider's stock after selling 582 shares during the quarter. Ostrum Asset Management's holdings in Intuitive Surgical were worth $5,307,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Bennett Selby Investments LP lifted its position in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after buying an additional 17 shares in the last quarter. Onefund LLC grew its position in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC increased its stake in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after buying an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last ninety days. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ISRG. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Evercore ISI decreased their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday. Piper Sandler cut their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday. Finally, CICC Research assumed coverage on Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price on the stock. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Trading Up 1.3 %

ISRG traded up $6.46 during mid-day trading on Friday, hitting $514.59. 1,997,621 shares of the stock were exchanged, compared to its average volume of 1,612,838. The firm's fifty day moving average is $513.65 and its two-hundred day moving average is $532.19. Intuitive Surgical, Inc. has a 1-year low of $367.39 and a 1-year high of $616.00. The company has a market cap of $183.29 billion, a PE ratio of 80.28, a PEG ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the company earned $1.50 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.